BioRem Inc. has seen a slight decline this week amidst a backdrop of significant order backlog announcements.
BioRem Inc. (BRM.V) has had a tough week in the market, with its stock dropping 3.27%. This decline contrasts with the company’s growth potential, as reflected in its strong financial metrics. Despite the recent downturn, BioRem's performance may attract investors looking for opportunities in the industrial sector.
Investor takeaway: While BioRem Inc. has reported impressive financial results and a substantial order backlog, recent stock performance indicates volatility that investors should monitor closely.
Advertisement
BioRem Inc.
BRM.V
BRM.V
BioRem Inc.
WealthAwesomeMarket cap
$58.50M
P/E
10.6x
52W high
$3.95
52W low
$1.87
1W change
-3.27%
Beta
0.86
Analyst Price Targets
Based on analyst covering BRM
Wall Street analysts forecast BRM stock price to rise 26.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$4.50
+26.8% Upside
Current Price
C$3.55
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BRM's historical volatility
30-Day Vol
62.1%
Annualized
90-Day Vol
48.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$4.24
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.77 | C$3.04 – C$4.67 |
| 60 trading days | C$4.00 | C$2.95 – C$5.41 |
| 90 trading days | C$4.24 | C$2.93 – C$6.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
BioRem Inc. Reports 33.96% Year-to-Date Growth Despite Recent Stock Decline
With a market cap of about C$58.5 million and a profit margin of 12.3%, BioRem Inc. remains a notable player in the industrial sector, even as its stock fluctuates.
Bull case
The company has reported record revenues and earnings before tax for the fiscal year ending December 31, 2025, along with a strong order backlog of $65.3 million. These factors indicate that BioRem is well-positioned for future growth.
Bear case
Despite these strong fundamentals, the stock price has declined, and trading volume is below average. This may suggest reduced investor interest or confidence in the short term.
Recent Price Action
Advertisement
BioRem Inc. closed at C$3.55, down 1.66% for the day and a total of 3.27% over the past week. However, the stock has seen a year-to-date increase of 33.96%, showing strong performance earlier in the year despite recent volatility.
Company News and Developments
There haven’t been any major news releases this week, but BioRem has gained attention for announcing record revenues and earnings before tax for 2025, with a reported 60% increase in earnings over 2024. The company also has a substantial order backlog of $65.3 million, highlighting its growth potential in the industrial sector.
Technical Picture
From a technical standpoint, BioRem's stock is currently trading above its 50-day moving average of C$3.40, reflecting a 4.5% increase. It is also significantly above its 200-day moving average of C$2.91, which is a 22.0% increase. The stock has a beta of 0.86, indicating lower volatility compared to the broader market. The 52-week range for BioRem is C$1.87 – C$3.95, with the current price sitting at 81% of this range. Recent trading volume of 11,273 shares is below the 20-day average volume of 20,245 shares, suggesting diminished trading activity.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
